News and Media

Latest News Release

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


Cardinal Health Latest News

Theranostics: Reimagining the standard of care


By Tiffany Olson, president of Nuclear & Precision Health Solutions at Cardinal Health

From HealthCare Business News magazine:

Precision medicine is an area of healthcare that targets treatment for a well-defined patient population, with the goal of improving safety, efficacy and outcomes. Theranostics take the concept of precision medicine a step further, targeting care for individual patients. In fact, the field has been called the epitome of personalized medicine. Simply put, theranostics combine a diagnostic radiopharmaceutical and therapeutic radiopharmaceutical, which are tailored to the patient at the cellular level.


Don’t miss out on any of our health care reporting: Subscribe today

At Cardinal Health, we provide the products, services and digital solutions to address health care’s most complicated challenges. Subscribe to our News Alerts and our Health Brief to get all of our latest news.